Pharmaceutical giant GlaxoSmithKline is calling for research proposals in non-communicable diseases targeting 11 sub-Saharan African countries.
Through its NCD Africa Open Lab, the company has a total of £1 million (US$1.24m) to spend. This will fund a minimum of 10 proposals, each to a maximum of £100,000.
Scientists and researchers from Cameroon, Ethiopia, Ghana, Ivory Coast, The Gambia, Kenya, Malawi, Nigeria, Senegal, Tanzania and Uganda are eligible to apply for the opportunity.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.